the HIX ($14.3bn in 2018), Medtech Tax (2.3%), pharma industry tax ($4.1bn in 2018) & Cadillac tax (effective 2020). As for the views by analysts... Biotech (+) — believe sector will outperform largely as pricing risk has diminished (although will remain in pockets) but pipelines/growth remains. Ying’s to

Nov-12 Feb-13 Aug-13 Nov-13 Feb-14 May-14 Aug-14 Nov-14 Feb-15 Nov-15 Feb-16 May-16 Aug-16 <= ol (A) Chart 12: Near multi-year flat call skew on Biotech (IBB) makes long call spreads an attractive option strategy to initiate or replace long positions to lock-in profits from the recent strong rally 55

arance in the U.S., Pfizer and its German partner BioNTech (BNTX) said Tuesday <a href="https://link.cnbc.co

wo-shot regimen in partnership with Germany&#39;s BioNTech (BNTX), hopes kids in that age group could be eli

2008); Technology commentator, CNN, New York (1999-2004); Regular guest on science and technology topics at Fox News, MSNBC, CNBC, NPR (1996-2004); Biotech commentator, This Week in Business, PBS, Washington, D.C. (1998-2000). Print journalism: Senior editor for science and senior writer at Business We

hat our analyst hosted (see link) as our sector specialist was up in Boston for the meeting. M&A is one of the primary reasons why we're BULLISH on Biotech — more in the write-up from yesterday on the Fear of Missing Biotech Basket — MLDIFOMB. From: Ens, Amanda Sent: Monday, August 01, 2016 2:53 PM T

From: Tazia Smith ii Sent: 4/23/2014 11:54:05 AM To: [email protected] CC: ; Paul Morris Vahe Stepanian [ Subject: WY and Biotech [CI Attachments: 182298_20140422_20140423_1.pdf Classification: Confidential Jeffrey - _] Nav Gupta Vinit Sahni Just posting you on your biotec

Micropattemed Surfaces for Control of Cell Shape, Position, and Function", Chen, C. S., Mrksich, M., Huang, S., Whitesides, G. M. and Ingber, D. E., Biotech. Frog, 1999, 14, 356.363. 633. "Fabrication of Glassy Carbon Microstructures by Soft Lithography", Schueller, O. 3. A., Brittain, S. T. and Whites

hat our analyst hosted (see link) as our sector specialist was up in Boston for the meeting. M&A is one of the =rimary reasons why we're BULLISH on Biotech — more in =he write-up from yesterday on the Fear of Missing Biotech Basket —=MLDIFOMB. From: Ens, Amanda Sent: Monday, August 01, 2016 2:53 PM T